Gestational diabetes: impact of home glucose monitoring on neonatal birth weight.
Two groups of 58 gestational diabetic women matched for age, prepregnancy weight, height, and parity were studied. The home glucose monitoring study group performed fasting and 1-hour postprandial capillary blood glucose testing after every meal. The control group was followed by conventional treatment. The incidence of macrosomia (birth weight of greater than or equal to 4000 gm) and large (greater than or equal to 90%) for gestational age infants was significantly reduced in the home glucose monitoring group. The mean birth weight of the study group was 3231 +/- 561 gm, while that of the control group was 3597 +/- 721 gm (p less than 0.002). Significantly more patients in the home glucose monitoring group were receiving insulin therapy (50% versus 21%). We believe that intensive home glucose monitoring will allow for the early identification of those gestational diabetic patients needing insulin and thus reduce the incidence of macrosomia and large for gestational age infants.
D000328:Adult; D001724:Birth Weight; D001786:Blood Glucose / Q000032:analysis*; D005260:Female; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D008991:Monitoring, Physiologic / Q000379:methods*; D010349:Patient Compliance; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000097:blood* / Q000188:drug therapy; D012648:Self Care
D001786:Blood Glucose; D007328:Insulin